A

Agilent Technologies IncNYSE A Stock Report

Last reporting period 31 Jul, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

40.763

Mega

Exchange

XNYS - New York Stock Exchange, Inc

A Stock Analysis

A

Neutral

Based on Eyestock quantitative analysis, A`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

92/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

19.2 %

Greatly undervalued

Market cap $B

40.763

Dividend yield

0.79 %

Shares outstanding

295.7 B

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,300 full-time employees. The company operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.

View Section: Eyestock Rating